Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Obesity
ADR ID BADD_A03103
ADR Hierarchy
14      Metabolism and nutrition disorders
14.03      Appetite and general nutritional disorders
14.03.02      General nutritional disorders NEC
14.03.02.009      Obesity
Description A disorder characterized by having a high amount of body fat. [CTCAE] A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). [MeSH]
MedDRA Code 10029883
MeSH ID D009765; D009767; D063766
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Adiposis | Gross obesity | Morbid obesity | Obesity | Obesity and other hyperalimentation | Obesity, unspecified | Other obesity and hyperalimentation | Adipositas | Adipositas per magna | Adipositas permagna | Childhood obesity
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02026Simvastatin0.000011%
BADD_D02029Sitagliptin0.000302%
BADD_D02047Sodium oxybate0.003031%
BADD_D02105Tacrolimus0.000446%
BADD_D02107Tafamidis0.002692%
BADD_D02147Telmisartan0.000260%
BADD_D02214Ticagrelor0.000925%
BADD_D02236Tofacitinib--
BADD_D02247Topiramate0.000101%
BADD_D02329Valproic acid0.000549%
BADD_D02331Valsartan0.000053%
BADD_D02337Varenicline0.000195%
BADD_D02346Venlafaxine0.000087%
BADD_D02407Upadacitinib0.001181%
BADD_D02443Tiotropium0.000057%
BADD_D02452Icatibant-
BADD_D02595Solriamfetol0.000137%
The 3th Page    First    Pre   3    Total 3 Pages
ADReCS-Target
ADR Term Drug Name Target